Table 1.
Comparison of Clinical Characteristics between UC Patients with ZNF83-WT and ZNF83-MUT in 99 UC Patients
| Variables | Total (Cases, %) | ZNF83-WT (%) | ZNF83-MUT (%) | p Value |
|---|---|---|---|---|
| Age group (years) | 0.1650 | |||
| <60 | 38 (38.4) | 28 (28.3) | 10 (10.1) | |
| ≥60 | 61 (61.6) | 53 (53.5) | 8 (8.1) | |
| Sex | 0.6784 | |||
| Female | 11 (11.1) | 9 (9.1) | 2 (2.0) | |
| Male | 88 (88.9) | 72 (72.7) | 16 (16.2) | |
| Tobacco smoking | 0.0215∗ | |||
| Smoker | 50 (50.5) | 36 (36.4) | 14 (14.1) | |
| Non-smoker | 49 (49.5) | 45 (45.5) | 4 (4.0) | |
| Family history of cancer | 0.6638 | |||
| Yes | 21 (21.2) | 16 (16.2) | 5 (5.0) | |
| No | 78 (78.8) | 65 (65.7) | 13 (13.1) | |
| Primary/relapsed | 0.1504 | |||
| Primary | 86 (86.9) | 68 (68.7) | 18 (18.2) | |
| Relapsed | 13 (13.1) | 13 (13.1) | 0 (0) | |
| Clinical stage | 0.0323∗ | |||
| Stage I+II | 58 (58.6) | 52 (52.5) | 6 (6.1) | |
| Stage III+IV | 41 (41.4) | 29 (29.3) | 12 (12.1) |
∗
p < 0.05, ∗∗p < 0.01. The p value was calculated by a χ2 test.